APA (7th ed.) Citation

Hozjainova, N. J., Tsareva, V. M., Brook, T. V., & Bezaltynnyh, M. S. (2016). POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION. Рациональная фармакотерапия в кардиологии, 5(2), 18-21. https://doi.org/10.1234/1819-6446-2009-2-18-21

Chicago Style (17th ed.) Citation

Hozjainova, N. J., V. M. Tsareva, T. V. Brook, and M. S. Bezaltynnyh. "POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION." Рациональная фармакотерапия в кардиологии 5, no. 2 (2016): 18-21. https://doi.org/10.1234/1819-6446-2009-2-18-21.

MLA (9th ed.) Citation

Hozjainova, N. J., et al. "POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION." Рациональная фармакотерапия в кардиологии, vol. 5, no. 2, 2016, pp. 18-21, https://doi.org/10.1234/1819-6446-2009-2-18-21.